Sarah James
Stock Analyst at Cantor Fitzgerald
(4.10)
# 1,645
Out of 5,088 analysts
505
Total ratings
56.4%
Success rate
4.9%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Reiterated: Buy | $10 | $8.73 | +14.55% | 9 | Oct 28, 2026 | |
| CNC Centene | Reiterated: Buy | $75 → $79 | $68.62 | +15.13% | 59 | Oct 27, 2026 | |
| SGRY Surgery Partners | Downgraded: Hold | $18 → $24 | $23.21 | +1.25% | 11 | Oct 26, 2026 | |
| MOH Molina Healthcare | Reiterated: Hold | $209 | $198.95 | +5.05% | 43 | Oct 21, 2026 | |
| HUM Humana | Upgraded: Buy | $300 → $460 | $417.56 | +10.16% | 40 | Oct 7, 2026 | |
| TEM Tempus AI | Initiated Coverage: Buy | $80 | $77.84 | +2.77% | 1 | Sep 2, 2026 | |
| CVRX CVRx, Inc. | Reiterated: Buy | $13 → $5 | $1.43 | +250.88% | 2 | Aug 17, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $21 | $13.01 | +61.41% | 2 | Aug 17, 2026 | |
| PGNY Progyny | Reiterated: Buy | $31 | $28.40 | +9.15% | 14 | Aug 6, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $15 | $2.32 | +546.55% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 | $29.46 | +1.83% | 17 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $194 | $176.61 | +9.85% | 37 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 | $270.57 | -9.45% | 29 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 | $478.08 | +9.81% | 35 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 → $110 | $90.33 | +21.78% | 23 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $450 | $422.02 | +6.63% | 29 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.2731 | +998.50% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 | $1.79 | +67.60% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $365 → $340 | $298.41 | +13.94% | 28 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.3058 | +2,189.08% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.97 | +101.51% | 1 | Feb 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $440 | $410.91 | +7.08% | 45 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $28 | $20.76 | n/a | 3 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 → $5 | $9.24 | n/a | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $5 | $13.26 | n/a | 3 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $128 → $103 | $193.31 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $57 | $36.62 | n/a | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $56 → $76 | $131.49 | n/a | 13 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $0.362 | n/a | 1 | Jun 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $96 → $80 | $86.44 | n/a | 7 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3 | $2.41 | n/a | 12 | Aug 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $290 | $448.76 | n/a | 1 | Oct 19, 2017 |
Teladoc Health
Oct 28, 2026
Reiterated: Buy
Price Target: $10
Current: $8.73
Upside: +14.55%
Centene
Oct 27, 2026
Reiterated: Buy
Price Target: $75 → $79
Current: $68.62
Upside: +15.13%
Surgery Partners
Oct 26, 2026
Downgraded: Hold
Price Target: $18 → $24
Current: $23.21
Upside: +1.25%
Molina Healthcare
Oct 21, 2026
Reiterated: Hold
Price Target: $209
Current: $198.95
Upside: +5.05%
Humana
Oct 7, 2026
Upgraded: Buy
Price Target: $300 → $460
Current: $417.56
Upside: +10.16%
Tempus AI
Sep 2, 2026
Initiated Coverage: Buy
Price Target: $80
Current: $77.84
Upside: +2.77%
CVRx, Inc.
Aug 17, 2026
Reiterated: Buy
Price Target: $13 → $5
Current: $1.43
Upside: +250.88%
NeuroPace
Aug 17, 2026
Reiterated: Buy
Price Target: $21
Current: $13.01
Upside: +61.41%
Progyny
Aug 6, 2026
Reiterated: Buy
Price Target: $31
Current: $28.40
Upside: +9.15%
LifeMD
Aug 5, 2026
Reiterated: Buy
Price Target: $15
Current: $2.32
Upside: +546.55%
Jul 29, 2026
Reiterated: Hold
Price Target: $30
Current: $29.46
Upside: +1.83%
Jul 28, 2026
Reiterated: Hold
Price Target: $194
Current: $176.61
Upside: +9.85%
Jul 23, 2026
Reiterated: Buy
Price Target: $245
Current: $270.57
Upside: -9.45%
Jul 14, 2026
Reiterated: Buy
Price Target: $525
Current: $478.08
Upside: +9.81%
Jul 7, 2026
Reiterated: Buy
Price Target: $95 → $110
Current: $90.33
Upside: +21.78%
Jul 7, 2026
Reiterated: Buy
Price Target: $400 → $450
Current: $422.02
Upside: +6.63%
May 8, 2026
Reiterated: Buy
Price Target: $3
Current: $0.2731
Upside: +998.50%
May 8, 2026
Reiterated: Hold
Price Target: $3
Current: $1.79
Upside: +67.60%
Apr 30, 2026
Reiterated: Buy
Price Target: $365 → $340
Current: $298.41
Upside: +13.94%
Apr 20, 2026
Reiterated: Buy
Price Target: $7
Current: $0.3058
Upside: +2,189.08%
Feb 15, 2026
Reiterated: Buy
Price Target: $8
Current: $3.97
Upside: +101.51%
Jan 28, 2026
Reiterated: Buy
Price Target: $440
Current: $410.91
Upside: +7.08%
Jun 13, 2025
Reiterated: Buy
Price Target: $33 → $28
Current: $20.76
Upside: n/a
Sep 15, 2022
Reiterated: Hold
Price Target: $6 → $5
Current: $9.24
Upside: n/a
Aug 19, 2022
Reiterated: Buy
Price Target: $7 → $5
Current: $13.26
Upside: n/a
Aug 16, 2022
Reiterated: Hold
Price Target: $128 → $103
Current: $193.31
Upside: n/a
Aug 5, 2022
Reiterated: Hold
Price Target: $50 → $57
Current: $36.62
Upside: n/a
Nov 23, 2020
Upgraded: Buy
Price Target: $56 → $76
Current: $131.49
Upside: n/a
Jun 15, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $0.362
Upside: n/a
Nov 11, 2019
Reiterated: Buy
Price Target: $96 → $80
Current: $86.44
Upside: n/a
Aug 7, 2019
Reiterated: Sell
Price Target: $4 → $3
Current: $2.41
Upside: n/a
Oct 19, 2017
Reiterated: Hold
Price Target: $290
Current: $448.76
Upside: n/a